Roles of CD4+ T and B cells in influenza virus infection

International Congress Series

Volumn 1219, Issue C, 2001, Pages 311-318

  Gerhard, Walter ^a   Mozdzanowska, Krystyna ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Antibody; Innate defense; Neutralization; Yield reduction

Indexed keywords

EID: 0242327854     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00644-6     Document Type: Article

References (26)

1. + T cells clear influenza virus by perforin or fas-dependent processes. J. Immunol. 159 (1997), 5197–5200.
2. + T cell response in influenza. Sem. Immunol. 4 (1992), 85–90.
3. + T cell memory in the absence of B cells and Ig. J. Immunol. 157 (1996), 2947–2952.
4. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239 (1997), 217–225.
5. + T cells is inefficient in the absence of B cells. J. Virol. 72 (1998), 882–885.
6. Epstein, S.L., Lo, C.-Y., Misplon, J.A., Bennink, J.R., Mechanisms of protective immunity in mice without antibodies. J. Immunol. 160 (1998), 322–327.
7. Leung, K.N., Ada, G.L., Different functions of subsets of effector T cells in murine influenza virus infection. Cell. Immunol. 67 (1982), 312–324.
8. Ochsenbein, A.F., Pinschewer, D.D., Odermatt, B., Ciurea, A., Hengartner, H., Zinkernagel, R.M., Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design. J. Immunol. 164 (2000), 6296–6302.
9. Scherle, P.A., Palladino, G., Gerhard, W., Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148 (1992), 212–217.
10. Mozdzanowska, K., Maiese, K., Gerhard, W., Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J. Immunol. 164 (2000), 2635–2643.
11. Baumgarth, N., Herman, O.C., Jager, G.C., Brown, L.E., Herzenberg, L.A., Chen, J., B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192 (2000), 271–280.
12. Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G., Maiese, K., Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159 (1997), 95–103.
13. Palladino, G., Mozdzanowska, K., Washko, G., Gerhard, W., Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69 (1995), 2075–2081.
14. Mozdzanowska, K., Furchner, M., Washko, G., Mozdzanowski, J., Gerhard, W., A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J. Virol. 71 (1997), 4347–4355.
15. Caton, A.J., Brownlee, G.G., Yewdell, J.W., Gerhard, W., The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31 (1982), 417–427.
16. Wiley, D.C., Skehel, J.J., The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56 (1987), 366–394.
17. Wilson, I.A., Cox, N.J., Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol., 1990, 8737–8771.
18. Mozdzanowska, K., Maiese, K., Furchner, M., Gerhard, W., Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology 254 (1999), 138–146.
19. Johansson, B.E., Bucher, D.J., Kilbourne, E.D., Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response by induce contrasting types of immunity to infection. J. Virol. 63 (1989), 1239–1246.
20. Frace, A.M., Klimov, A.I., Rowe, T., Black, R.A., Katz, J.M., Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 17 (1999), 2237–2244.
21. Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Min Jou, W., Fiers, W., A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 5 (1999), 1119–1157.
22. Zebedee, S.L., Lamb, R.A., Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 62 (1988), 2762–2772.
23. Neuberger, M.S., Rajewsky, K., Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11 (1981), 1012–1016.
24. Ravetch, J.V., Kinet, J.P., Fc receptors. Annu. Rev. Immunol. 9 (1991), 457–492.
25. Hulett, M.D., Hogarth, P.M., Molecular basis of Fc receptor function. Adv. Immunol. 57 (1994), 1–96.
26. Graham, M.B., Braciale, T.J., Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186 (1997), 2063–2068.